E. B. Batomunkueva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
E. B. Batomunkueva has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Pashkov
Lapino Clinical Hospital, “Mother and Child” Group of Companies
1 shared publication - Alina A. Dokshukina
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
1 shared publication - Grigory S. Vasiliev
Kulakov Sientific Centre for Obstetrics, Gynecology and Perinatology
1 shared publication - Krapivkin Alexey Igorevich
Pirogov Russian National Medical University; V.F. Voyno-Yasenetsky Scientific and Practical Center for Specialized Assistance for Children of the Department of Healthcare of Moscow
1 shared publication - N. P. Prokopyeva
Voino-Yasenetsky Scientific Center for Specialized Medical Care for Children
1 shared publication - T. E. Areyan
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- Open Access
- 30 December 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (6) , 68-76
Leukoencephalopathy, developmental delay, and episodic neurological regression syndrome (LEUDEN)
We describe a clinical case of leukencephalopathy, developmental delay, and episodic neurologic regression (LEUDEN, OMIM 618877) associated with variants in the EIF2AK2 gene, with an emphasis on clinico-pathogenetic links and potential therapeutic targets. A 2-year-old boy presented with psychomotor delay, spastic tetraparesis, and fever-induced episodes of regression; brain MRI showed hypomyelination and white-matter atrophy. Whole-exome sequencing identified a de novo pathogenic EIF2AK2 variant, c.325G>T (p.Ala109Ser, NM_001135651.3). The synthesis of clinical, neuroimaging, and genetic data is consistent with chronic hyperactivation of the integrated stress response (ISR) via the PKR–eIF2α pathway, leading to sustained eIF2α phosphorylation, impaired synthesis of myelin proteins, activation of apoptosis, and synaptic dysfunction; external stressors (infections) act as triggers of transient deterioration manifesting as regression of skills. The phenotype may mimic cerebral palsy with episodes of regression, underscoring the need for early molecular genetic confirmation in pediatric hypomyelination. The pathogenetic involvement of the ISR highlights the promise of targeted modulation of this pathway (e.g., ISR inhibitors), although the clinical efficacy of such strategies in LEUDEN requires further evaluation in controlled studies; early diagnosis and patient stratification are key to developing personalized treatment approaches.
- 30 December 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (6) , 68-76
Open AccessLeukoencephalopathy, developmental delay, and episodic neurological regression syndrome (LEUDEN)
We describe a clinical case of leukencephalopathy, developmental delay, and episodic neurologic regression (LEUDEN, OMIM 618877) associated with variants in the EIF2AK2 gene, with an emphasis on clinico-pathogenetic links and potential therapeutic targets. A 2-year-old boy presented with psychomotor delay, spastic tetraparesis, and fever-induced episodes of regression; brain MRI showed hypomyelination and white-matter atrophy. Whole-exome sequencing identified a de novo pathogenic EIF2AK2 variant, c.325G>T (p.Ala109Ser, NM_001135651.3). The synthesis of clinical, neuroimaging, and genetic data is consistent with chronic hyperactivation of the integrated stress response (ISR) via the PKR–eIF2α pathway, leading to sustained eIF2α phosphorylation, impaired synthesis of myelin proteins, activation of apoptosis, and synaptic dysfunction; external stressors (infections) act as triggers of transient deterioration manifesting as regression of skills. The phenotype may mimic cerebral palsy with episodes of regression, underscoring the need for early molecular genetic confirmation in pediatric hypomyelination. The pathogenetic involvement of the ISR highlights the promise of targeted modulation of this pathway (e.g., ISR inhibitors), although the clinical efficacy of such strategies in LEUDEN requires further evaluation in controlled studies; early diagnosis and patient stratification are key to developing personalized treatment approaches.